How AI Is Aiming at the Bad Math of Drug Development

Robert Marcus
Nov 29, 2021

Related news

Nov 26
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Medical Tech Tops Deloitte’s Technology 500 Rankings

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Exscientia Files For $100M IPO

Dec 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

MGI estimates big savings from LS research practices

Nov 5
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Is AI delivering on the hype?

Oct 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

With the Metaverse on the way, an AI Bill of Rights is urgent

Nov 27
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Bright New Age of Venture Capital

Dec 8
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Fund commits to $350M dedicated LS investments

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

European Biotech Investors Cap Off Record Year in Fundraising

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Accenture’s Julie Sweet: A.I. can transform companies, creating ‘responsibility and possibility’ for CEOs

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie